Skip to content
Home/Companies/Biotech/Forward Pharma

Forward Pharma

Biotech·Denmark·Exited 2014·Held 8yr
Entry
2006
Hold
8yr
Exit
2014

Who owns Forward Pharma?

Forward Pharma was owned by Nordic Biotech Advisors through Nordic Biotech K/S (2002 vintage) from 2006 to 2014, exited via IPO.

Hand-verified · updated 2026-08-18

Nordic Biotech Advisors
Investor
Nordic Biotech Advisors
Nordic Biotech K/S · 2002 · Life Sciences VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2014

More from Nordic Biotech K/S

Other portfolio companies in the same fund.

Curalogic
Exited 2006
BiotechDenmark· 2004
Gastrotech Pharma
Active
BiotechDenmark· 2003
Osteologix
Exited 2006
BiotechDenmark· 2003
LifeCycle Pharma
Exited 2006
PharmaDenmark· 2002

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Forward Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Forward Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Forward Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue